European Journal of Oncology Vol.21, No 2 (2016)

View European Journal of Oncology Vol.21, No 2 (2016)

Published: 2016-07-01

Clinicopathologic associations of BRAF mutation status in patients with metastatic melanoma

Dorota Kwapisz, Agnieszka Dansonka-Mieszkowska, Tomasz Switaj, Slawomir Falkowski, Piotr Rutkowski

89-99
- PDF
Efficacy of the neutrophil-lymphocyte ratio on biochemical recurrence in patients treated with radical prostatectomy

Hakan Türk, Sıtkı Ün, Osman Koca, Mustafa Karabiçak, Batuhan Ergani, Gökhan Koç, Hüseyin Tarhan, Ferruh Zorlu

100-107
- PDF
Interventional treatment of endobronchial hamartomas and lipomas

Mehmet Akif Özgül, Erdogan Çetinkaya, Şule Gül, Huseyin Erhan Dinçer, Murat Acat, Hilal Boyacı, Güler Özgül

108-112
- PDF

Current situation in Polish nuclear medicine and Polish example of model Nuclear Medicine Centre meeting European Union requirements

Jan Jakub Lica, Grzegorz Jan Grabe, Tomasz Bandurski

113-122
- PDF

Oxaliplatin-based second-line chemotherapy in neuroendocrine carcinomas. A case series and review of the literature

Salvatore Galdy, Luigi Funicelli, Andrea Luciani, Dario Giuffrida, Francesca Spada, Chiara Alessandra Cella, Sabina Murgioni, Anna Maria Frezza, Nicola Fazio

123-129
- PDF
A rare case of CD5 positive extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) arising in a female breast after surgical excision of an inflammatory pseudotumor

Giovanni Branca, Antonio Ieni, Eleonora Irato, Giuseppe La Malfa, Cesare Lorenzini, Fabio Guccione, Renato Palmeri

130-137
- PDF